Array ( [ID] => 335 [~ID] => 335 [IBLOCK_ID] => 39 [~IBLOCK_ID] => 39 [IBLOCK_SECTION_ID] => [~IBLOCK_SECTION_ID] => [NAME] => BIOCARD DELIVERED THE CORONAVIRUS VACCINE TO ALL REGIONS OF RUSSIA [~NAME] => BIOCARD DELIVERED THE CORONAVIRUS VACCINE TO ALL REGIONS OF RUSSIA [ACTIVE_FROM] => 12/17/2020 [~ACTIVE_FROM] => 12/17/2020 [TIMESTAMP_X] => 08/11/2021 04:32:17 pm [~TIMESTAMP_X] => 08/11/2021 04:32:17 pm [DETAIL_PAGE_URL] => /en/news/biocard-dostavil-vaktsinu-ot-koronovirusa-vo-vse-regiony-rossii/ [~DETAIL_PAGE_URL] => /en/news/biocard-dostavil-vaktsinu-ot-koronovirusa-vo-vse-regiony-rossii/ [LIST_PAGE_URL] => /en/news/ [~LIST_PAGE_URL] => /en/news/ [DETAIL_TEXT] => [~DETAIL_TEXT] => [DETAIL_TEXT_TYPE] => text [~DETAIL_TEXT_TYPE] => text [PREVIEW_TEXT] => Today, "Biocard Logistics" has completed the delivery of the first batches of a vaccine against a new coronavirus infection to all regions of Russia. Since September of this year, a complete logistics chain for the vaccination process with a continuous «cold chain» has been deployed in the capital for the storage and transportation of the vaccine. It includes the storage and transportation of the drug, ensuring the correct storage conditions.

Storage and transportation of the Gam-COVID-Vac vaccine are performed at a temperature not higher than -18°C in the area protected from light. Biocard Logistics has successfully provided a continuous «cold chain» of the first batches of the vaccine at all stages of delivery. For more than three months, BIOCARD has been delivering the coronavirus vaccine to medical institutions using specialized vehicles and equipment of own production — Safepack isothermal insulated containers, freezer plates of phase-changeable materials, temperature recorders, and a mobile application. The smart sensor integrated into the insulated container made it possible to monitor the condition of the cargo and the temperature inside the insulated container online throughout the entire logistics chain. With the benefit of the elaborated infrastructure, the company successfully managed the volume of deliveries.



According to the results of November, the BIOCARD production site produced 1,500 units of SafePack insulated containers and 50,000 units of SafePack freezer plates of various models. To ensure the continuity of the technological chain, the volume of production of insulated containers and SafePack freezer plates was increased by 2 times. Currently, an additional production site with an area of 2,300 sq. m. has been launched for the production of insulated containers and freezer plates.

During the pandemic, we have gained a special experience of large-scale mobilization of the company's resources. All the processes were developed to the finest details. The trained staff and the available equipment made it possible to organize the delivery of vaccines properly, promptly, and to meet all demands.

[~PREVIEW_TEXT] => Today, "Biocard Logistics" has completed the delivery of the first batches of a vaccine against a new coronavirus infection to all regions of Russia. Since September of this year, a complete logistics chain for the vaccination process with a continuous «cold chain» has been deployed in the capital for the storage and transportation of the vaccine. It includes the storage and transportation of the drug, ensuring the correct storage conditions.

Storage and transportation of the Gam-COVID-Vac vaccine are performed at a temperature not higher than -18°C in the area protected from light. Biocard Logistics has successfully provided a continuous «cold chain» of the first batches of the vaccine at all stages of delivery. For more than three months, BIOCARD has been delivering the coronavirus vaccine to medical institutions using specialized vehicles and equipment of own production — Safepack isothermal insulated containers, freezer plates of phase-changeable materials, temperature recorders, and a mobile application. The smart sensor integrated into the insulated container made it possible to monitor the condition of the cargo and the temperature inside the insulated container online throughout the entire logistics chain. With the benefit of the elaborated infrastructure, the company successfully managed the volume of deliveries.



According to the results of November, the BIOCARD production site produced 1,500 units of SafePack insulated containers and 50,000 units of SafePack freezer plates of various models. To ensure the continuity of the technological chain, the volume of production of insulated containers and SafePack freezer plates was increased by 2 times. Currently, an additional production site with an area of 2,300 sq. m. has been launched for the production of insulated containers and freezer plates.

During the pandemic, we have gained a special experience of large-scale mobilization of the company's resources. All the processes were developed to the finest details. The trained staff and the available equipment made it possible to organize the delivery of vaccines properly, promptly, and to meet all demands.

[PREVIEW_TEXT_TYPE] => html [~PREVIEW_TEXT_TYPE] => html [PREVIEW_PICTURE] => Array ( [ID] => 979 [TIMESTAMP_X] => Bitrix\Main\Type\DateTime Object ( [userTimeEnabled:protected] => 1 [value:protected] => DateTime Object ( [date] => 2021-08-11 16:32:17.000000 [timezone_type] => 3 [timezone] => Europe/Moscow ) ) [MODULE_ID] => iblock [HEIGHT] => 300 [WIDTH] => 367 [FILE_SIZE] => 22692 [CONTENT_TYPE] => image/jpeg [SUBDIR] => iblock/120 [FILE_NAME] => 12081c2d75be9d8dacc196a176f9201d.jpg [ORIGINAL_NAME] => 12081c2d75be9d8dacc196a176f9201d.jpg [DESCRIPTION] => [HANDLER_ID] => [EXTERNAL_ID] => f4671ac2e0cf057ccb3e40fe8abe7fb8 [~src] => [SRC] => /upload/iblock/120/12081c2d75be9d8dacc196a176f9201d.jpg [UNSAFE_SRC] => /upload/iblock/120/12081c2d75be9d8dacc196a176f9201d.jpg [SAFE_SRC] => /upload/iblock/120/12081c2d75be9d8dacc196a176f9201d.jpg [ALT] => BIOCARD DELIVERED THE CORONAVIRUS VACCINE TO ALL REGIONS OF RUSSIA [TITLE] => BIOCARD DELIVERED THE CORONAVIRUS VACCINE TO ALL REGIONS OF RUSSIA ) [~PREVIEW_PICTURE] => 979 [LANG_DIR] => /en/ [~LANG_DIR] => /en/ [CODE] => biocard-dostavil-vaktsinu-ot-koronovirusa-vo-vse-regiony-rossii [~CODE] => biocard-dostavil-vaktsinu-ot-koronovirusa-vo-vse-regiony-rossii [EXTERNAL_ID] => 335 [~EXTERNAL_ID] => 335 [IBLOCK_TYPE_ID] => news [~IBLOCK_TYPE_ID] => news [IBLOCK_CODE] => [~IBLOCK_CODE] => [IBLOCK_EXTERNAL_ID] => [~IBLOCK_EXTERNAL_ID] => [LID] => s2 [~LID] => s2 [EDIT_LINK] => [DELETE_LINK] => [DISPLAY_ACTIVE_FROM] => 17.12.2020 [FIELDS] => Array ( ) [DISPLAY_PROPERTIES] => Array ( ) [IPROPERTY_VALUES] => Array ( ) )

Array ( [ID] => 336 [~ID] => 336 [IBLOCK_ID] => 39 [~IBLOCK_ID] => 39 [IBLOCK_SECTION_ID] => [~IBLOCK_SECTION_ID] => [NAME] => NEW TESTIMONIAL FROM THE CLIENT [~NAME] => NEW TESTIMONIAL FROM THE CLIENT [ACTIVE_FROM] => 10/27/2020 [~ACTIVE_FROM] => 10/27/2020 [TIMESTAMP_X] => 08/11/2021 04:32:35 pm [~TIMESTAMP_X] => 08/11/2021 04:32:35 pm [DETAIL_PAGE_URL] => /en/news/novyy-otzyv-ot-klienta/ [~DETAIL_PAGE_URL] => /en/news/novyy-otzyv-ot-klienta/ [LIST_PAGE_URL] => /en/news/ [~LIST_PAGE_URL] => /en/news/ [DETAIL_TEXT] => [~DETAIL_TEXT] => [DETAIL_TEXT_TYPE] => text [~DETAIL_TEXT_TYPE] => text [PREVIEW_TEXT] => We are happy to receive another testimonial from our client!


[~PREVIEW_TEXT] => We are happy to receive another testimonial from our client!


[PREVIEW_TEXT_TYPE] => html [~PREVIEW_TEXT_TYPE] => html [PREVIEW_PICTURE] => Array ( [ID] => 980 [TIMESTAMP_X] => Bitrix\Main\Type\DateTime Object ( [userTimeEnabled:protected] => 1 [value:protected] => DateTime Object ( [date] => 2021-08-11 16:32:35.000000 [timezone_type] => 3 [timezone] => Europe/Moscow ) ) [MODULE_ID] => iblock [HEIGHT] => 300 [WIDTH] => 367 [FILE_SIZE] => 17525 [CONTENT_TYPE] => image/jpeg [SUBDIR] => iblock/e19 [FILE_NAME] => e19c0035f8321b9b4e22440e6267babc.jpg [ORIGINAL_NAME] => e19c0035f8321b9b4e22440e6267babc.jpg [DESCRIPTION] => [HANDLER_ID] => [EXTERNAL_ID] => a9759ac8e021352d7e470d43769d448e [~src] => [SRC] => /upload/iblock/e19/e19c0035f8321b9b4e22440e6267babc.jpg [UNSAFE_SRC] => /upload/iblock/e19/e19c0035f8321b9b4e22440e6267babc.jpg [SAFE_SRC] => /upload/iblock/e19/e19c0035f8321b9b4e22440e6267babc.jpg [ALT] => NEW TESTIMONIAL FROM THE CLIENT [TITLE] => NEW TESTIMONIAL FROM THE CLIENT ) [~PREVIEW_PICTURE] => 980 [LANG_DIR] => /en/ [~LANG_DIR] => /en/ [CODE] => novyy-otzyv-ot-klienta [~CODE] => novyy-otzyv-ot-klienta [EXTERNAL_ID] => 336 [~EXTERNAL_ID] => 336 [IBLOCK_TYPE_ID] => news [~IBLOCK_TYPE_ID] => news [IBLOCK_CODE] => [~IBLOCK_CODE] => [IBLOCK_EXTERNAL_ID] => [~IBLOCK_EXTERNAL_ID] => [LID] => s2 [~LID] => s2 [EDIT_LINK] => [DELETE_LINK] => [DISPLAY_ACTIVE_FROM] => 27.10.2020 [FIELDS] => Array ( ) [DISPLAY_PROPERTIES] => Array ( ) [IPROPERTY_VALUES] => Array ( ) )

Array ( [ID] => 337 [~ID] => 337 [IBLOCK_ID] => 39 [~IBLOCK_ID] => 39 [IBLOCK_SECTION_ID] => [~IBLOCK_SECTION_ID] => [NAME] => BIOCARD EXHIBITED THE SMART ECOSYSTEM SAFEPACK AT THE FORUM [~NAME] => BIOCARD EXHIBITED THE SMART ECOSYSTEM SAFEPACK AT THE FORUM [ACTIVE_FROM] => 10/15/2020 [~ACTIVE_FROM] => 10/15/2020 [TIMESTAMP_X] => 08/11/2021 04:32:59 pm [~TIMESTAMP_X] => 08/11/2021 04:32:59 pm [DETAIL_PAGE_URL] => /en/news/biocard-predstavil-na-forume-umnuyu-ekosistemu-safepack/ [~DETAIL_PAGE_URL] => /en/news/biocard-predstavil-na-forume-umnuyu-ekosistemu-safepack/ [LIST_PAGE_URL] => /en/news/ [~LIST_PAGE_URL] => /en/news/ [DETAIL_TEXT] => [~DETAIL_TEXT] => [DETAIL_TEXT_TYPE] => text [~DETAIL_TEXT_TYPE] => text [PREVIEW_TEXT] => BIOCARD made a presentation at the II International Conference SCM Pharm: "Logistics of Medicines", where we spoke about our new ecosystem for maintaining the «cold chain».

The SafePack ecosystem consists of SafePack insulated containers that support a pre-set temperature for up to 10 days, a new generation SafePack Smart Sensors, and mobile applications for customers and couriers.

During the conference, new opportunities for maintaining the «cold chain» and reducing the percentage of temperature failures from the total number of deliveries were demonstrated. [~PREVIEW_TEXT] => BIOCARD made a presentation at the II International Conference SCM Pharm: "Logistics of Medicines", where we spoke about our new ecosystem for maintaining the «cold chain».

The SafePack ecosystem consists of SafePack insulated containers that support a pre-set temperature for up to 10 days, a new generation SafePack Smart Sensors, and mobile applications for customers and couriers.

During the conference, new opportunities for maintaining the «cold chain» and reducing the percentage of temperature failures from the total number of deliveries were demonstrated. [PREVIEW_TEXT_TYPE] => html [~PREVIEW_TEXT_TYPE] => html [PREVIEW_PICTURE] => Array ( [ID] => 981 [TIMESTAMP_X] => Bitrix\Main\Type\DateTime Object ( [userTimeEnabled:protected] => 1 [value:protected] => DateTime Object ( [date] => 2021-08-11 16:32:59.000000 [timezone_type] => 3 [timezone] => Europe/Moscow ) ) [MODULE_ID] => iblock [HEIGHT] => 300 [WIDTH] => 367 [FILE_SIZE] => 30587 [CONTENT_TYPE] => image/jpeg [SUBDIR] => iblock/79d [FILE_NAME] => 79dd81019d7f6e658ded3a5d0bb6e79a.jpg [ORIGINAL_NAME] => 79dd81019d7f6e658ded3a5d0bb6e79a.jpg [DESCRIPTION] => [HANDLER_ID] => [EXTERNAL_ID] => b97693fafd21405e08ed85bb5cea3614 [~src] => [SRC] => /upload/iblock/79d/79dd81019d7f6e658ded3a5d0bb6e79a.jpg [UNSAFE_SRC] => /upload/iblock/79d/79dd81019d7f6e658ded3a5d0bb6e79a.jpg [SAFE_SRC] => /upload/iblock/79d/79dd81019d7f6e658ded3a5d0bb6e79a.jpg [ALT] => BIOCARD EXHIBITED THE SMART ECOSYSTEM SAFEPACK AT THE FORUM [TITLE] => BIOCARD EXHIBITED THE SMART ECOSYSTEM SAFEPACK AT THE FORUM ) [~PREVIEW_PICTURE] => 981 [LANG_DIR] => /en/ [~LANG_DIR] => /en/ [CODE] => biocard-predstavil-na-forume-umnuyu-ekosistemu-safepack [~CODE] => biocard-predstavil-na-forume-umnuyu-ekosistemu-safepack [EXTERNAL_ID] => 337 [~EXTERNAL_ID] => 337 [IBLOCK_TYPE_ID] => news [~IBLOCK_TYPE_ID] => news [IBLOCK_CODE] => [~IBLOCK_CODE] => [IBLOCK_EXTERNAL_ID] => [~IBLOCK_EXTERNAL_ID] => [LID] => s2 [~LID] => s2 [EDIT_LINK] => [DELETE_LINK] => [DISPLAY_ACTIVE_FROM] => 15.10.2020 [FIELDS] => Array ( ) [DISPLAY_PROPERTIES] => Array ( ) [IPROPERTY_VALUES] => Array ( ) )

Array ( [ID] => 338 [~ID] => 338 [IBLOCK_ID] => 39 [~IBLOCK_ID] => 39 [IBLOCK_SECTION_ID] => [~IBLOCK_SECTION_ID] => [NAME] => VENEZUELAN PRESIDENT MADURO THANKS RUSSIA FOR CORONAVIRUS VACCINE SUPPLY [~NAME] => VENEZUELAN PRESIDENT MADURO THANKS RUSSIA FOR CORONAVIRUS VACCINE SUPPLY [ACTIVE_FROM] => 10/03/2020 [~ACTIVE_FROM] => 10/03/2020 [TIMESTAMP_X] => 08/11/2021 04:33:19 pm [~TIMESTAMP_X] => 08/11/2021 04:33:19 pm [DETAIL_PAGE_URL] => /en/news/maduro-poblagodaril-rossiyu-za-postavku-vaktsiny-sputnik-v/ [~DETAIL_PAGE_URL] => /en/news/maduro-poblagodaril-rossiyu-za-postavku-vaktsiny-sputnik-v/ [LIST_PAGE_URL] => /en/news/ [~LIST_PAGE_URL] => /en/news/ [DETAIL_TEXT] => [~DETAIL_TEXT] => [DETAIL_TEXT_TYPE] => text [~DETAIL_TEXT_TYPE] => text [PREVIEW_TEXT] => Venezuelan leader Nicolas Maduro thanked Russian President Vladimir Putin and Russian citizens for the delivery of the first batch of coronavirus vaccines to the Republic. The first batch of the Russian «Sputnik V» vaccine was transported in SafePack insulated containers manufactured by BIOCARD. SafePack insulated containers are high-tech containers of phase-changeable materials and reliably protect against ambient factors: even at a constant external temperature of - 20°C or +30°C they will maintain the required temperature range for more than 10 days. The guarantee of the temperature of transportation is specified in the contract.



«Sputnik V» is already here! We have become the first country in the Western Hemisphere to launch the third phase of clinical studies of this coronavirus vaccine. On behalf of the Venezuelan people, I thank Russian President Vladimir Putin and the Russian people for their solidarity, " — Maduro wrote on Twitter.

    

Earlier, the Executive Vice President of Venezuela, Delcy Rodriguez, said that the country had received the first batch of the Russian "Sputnik V» vaccine against the COVID-19 infection.

Venezuelan President Nicolas Maduro said that the country's government, in collaboration with scientists, should analyze how the coronavirus is treated in Russia. [~PREVIEW_TEXT] => Venezuelan leader Nicolas Maduro thanked Russian President Vladimir Putin and Russian citizens for the delivery of the first batch of coronavirus vaccines to the Republic. The first batch of the Russian «Sputnik V» vaccine was transported in SafePack insulated containers manufactured by BIOCARD. SafePack insulated containers are high-tech containers of phase-changeable materials and reliably protect against ambient factors: even at a constant external temperature of - 20°C or +30°C they will maintain the required temperature range for more than 10 days. The guarantee of the temperature of transportation is specified in the contract.



«Sputnik V» is already here! We have become the first country in the Western Hemisphere to launch the third phase of clinical studies of this coronavirus vaccine. On behalf of the Venezuelan people, I thank Russian President Vladimir Putin and the Russian people for their solidarity, " — Maduro wrote on Twitter.

    

Earlier, the Executive Vice President of Venezuela, Delcy Rodriguez, said that the country had received the first batch of the Russian "Sputnik V» vaccine against the COVID-19 infection.

Venezuelan President Nicolas Maduro said that the country's government, in collaboration with scientists, should analyze how the coronavirus is treated in Russia. [PREVIEW_TEXT_TYPE] => html [~PREVIEW_TEXT_TYPE] => html [PREVIEW_PICTURE] => Array ( [ID] => 982 [TIMESTAMP_X] => Bitrix\Main\Type\DateTime Object ( [userTimeEnabled:protected] => 1 [value:protected] => DateTime Object ( [date] => 2021-08-11 16:33:19.000000 [timezone_type] => 3 [timezone] => Europe/Moscow ) ) [MODULE_ID] => iblock [HEIGHT] => 300 [WIDTH] => 367 [FILE_SIZE] => 27664 [CONTENT_TYPE] => image/jpeg [SUBDIR] => iblock/4ed [FILE_NAME] => 4ed7fb604e99702882df5d244621b98c.jpg [ORIGINAL_NAME] => 4ed7fb604e99702882df5d244621b98c.jpg [DESCRIPTION] => [HANDLER_ID] => [EXTERNAL_ID] => 5d2146967fb036d0d691c8f982ab0d4a [~src] => [SRC] => /upload/iblock/4ed/4ed7fb604e99702882df5d244621b98c.jpg [UNSAFE_SRC] => /upload/iblock/4ed/4ed7fb604e99702882df5d244621b98c.jpg [SAFE_SRC] => /upload/iblock/4ed/4ed7fb604e99702882df5d244621b98c.jpg [ALT] => VENEZUELAN PRESIDENT MADURO THANKS RUSSIA FOR CORONAVIRUS VACCINE SUPPLY [TITLE] => VENEZUELAN PRESIDENT MADURO THANKS RUSSIA FOR CORONAVIRUS VACCINE SUPPLY ) [~PREVIEW_PICTURE] => 982 [LANG_DIR] => /en/ [~LANG_DIR] => /en/ [CODE] => maduro-poblagodaril-rossiyu-za-postavku-vaktsiny-sputnik-v [~CODE] => maduro-poblagodaril-rossiyu-za-postavku-vaktsiny-sputnik-v [EXTERNAL_ID] => 338 [~EXTERNAL_ID] => 338 [IBLOCK_TYPE_ID] => news [~IBLOCK_TYPE_ID] => news [IBLOCK_CODE] => [~IBLOCK_CODE] => [IBLOCK_EXTERNAL_ID] => [~IBLOCK_EXTERNAL_ID] => [LID] => s2 [~LID] => s2 [EDIT_LINK] => [DELETE_LINK] => [DISPLAY_ACTIVE_FROM] => 03.10.2020 [FIELDS] => Array ( ) [DISPLAY_PROPERTIES] => Array ( ) [IPROPERTY_VALUES] => Array ( ) )

Array ( [ID] => 339 [~ID] => 339 [IBLOCK_ID] => 39 [~IBLOCK_ID] => 39 [IBLOCK_SECTION_ID] => [~IBLOCK_SECTION_ID] => [NAME] => NEWS ON THE RBC TV CHANNEL  [~NAME] => NEWS ON THE RBC TV CHANNEL  [ACTIVE_FROM] => 09/25/2020 [~ACTIVE_FROM] => 09/25/2020 [TIMESTAMP_X] => 08/11/2021 04:33:35 pm [~TIMESTAMP_X] => 08/11/2021 04:33:35 pm [DETAIL_PAGE_URL] => /en/news/semka-na-telekanale-rbk/ [~DETAIL_PAGE_URL] => /en/news/semka-na-telekanale-rbk/ [LIST_PAGE_URL] => /en/news/ [~LIST_PAGE_URL] => /en/news/ [DETAIL_TEXT] => [~DETAIL_TEXT] => [DETAIL_TEXT_TYPE] => text [~DETAIL_TEXT_TYPE] => text [PREVIEW_TEXT] => On September 19 in the studio of the RBC TV channel, Oleg Baykov spoke about the specifics and challenges of transporting the «Sputnik V» vaccine  #RBC #biocard #safepack [~PREVIEW_TEXT] => On September 19 in the studio of the RBC TV channel, Oleg Baykov spoke about the specifics and challenges of transporting the «Sputnik V» vaccine  #RBC #biocard #safepack [PREVIEW_TEXT_TYPE] => html [~PREVIEW_TEXT_TYPE] => html [PREVIEW_PICTURE] => Array ( [ID] => 983 [TIMESTAMP_X] => Bitrix\Main\Type\DateTime Object ( [userTimeEnabled:protected] => 1 [value:protected] => DateTime Object ( [date] => 2021-08-11 16:33:35.000000 [timezone_type] => 3 [timezone] => Europe/Moscow ) ) [MODULE_ID] => iblock [HEIGHT] => 300 [WIDTH] => 367 [FILE_SIZE] => 22543 [CONTENT_TYPE] => image/jpeg [SUBDIR] => iblock/fff [FILE_NAME] => fff484ea8b0b19fb602559dcd1ec8006.jpg [ORIGINAL_NAME] => fff484ea8b0b19fb602559dcd1ec8006.jpg [DESCRIPTION] => [HANDLER_ID] => [EXTERNAL_ID] => bc2c0b684219eead9732ba2a1fc3e252 [~src] => [SRC] => /upload/iblock/fff/fff484ea8b0b19fb602559dcd1ec8006.jpg [UNSAFE_SRC] => /upload/iblock/fff/fff484ea8b0b19fb602559dcd1ec8006.jpg [SAFE_SRC] => /upload/iblock/fff/fff484ea8b0b19fb602559dcd1ec8006.jpg [ALT] => NEWS ON THE RBC TV CHANNEL  [TITLE] => NEWS ON THE RBC TV CHANNEL  ) [~PREVIEW_PICTURE] => 983 [LANG_DIR] => /en/ [~LANG_DIR] => /en/ [CODE] => semka-na-telekanale-rbk [~CODE] => semka-na-telekanale-rbk [EXTERNAL_ID] => 339 [~EXTERNAL_ID] => 339 [IBLOCK_TYPE_ID] => news [~IBLOCK_TYPE_ID] => news [IBLOCK_CODE] => [~IBLOCK_CODE] => [IBLOCK_EXTERNAL_ID] => [~IBLOCK_EXTERNAL_ID] => [LID] => s2 [~LID] => s2 [EDIT_LINK] => [DELETE_LINK] => [DISPLAY_ACTIVE_FROM] => 25.09.2020 [FIELDS] => Array ( ) [DISPLAY_PROPERTIES] => Array ( ) [IPROPERTY_VALUES] => Array ( ) )

Array ( [ID] => 340 [~ID] => 340 [IBLOCK_ID] => 39 [~IBLOCK_ID] => 39 [IBLOCK_SECTION_ID] => [~IBLOCK_SECTION_ID] => [NAME] => BIOCARD OFFERS A NEW SERVICE: FTL-TRANSPORTATION [~NAME] => BIOCARD OFFERS A NEW SERVICE: FTL-TRANSPORTATION [ACTIVE_FROM] => 09/17/2020 [~ACTIVE_FROM] => 09/17/2020 [TIMESTAMP_X] => 08/11/2021 04:33:45 pm [~TIMESTAMP_X] => 08/11/2021 04:33:45 pm [DETAIL_PAGE_URL] => /en/news/biocard-otkryvaet-novoe-napravlenie-ftl-perevozka/ [~DETAIL_PAGE_URL] => /en/news/biocard-otkryvaet-novoe-napravlenie-ftl-perevozka/ [LIST_PAGE_URL] => /en/news/ [~LIST_PAGE_URL] => /en/news/ [DETAIL_TEXT] => [~DETAIL_TEXT] => [DETAIL_TEXT_TYPE] => text [~DETAIL_TEXT_TYPE] => text [PREVIEW_TEXT] => We are pleased to inform you that starting from September 17, BIOCARD offers FTL transportation using its fleet. It's even more convenient now! Competitive rates. Experienced drivers. All directions. Cargo safety. [~PREVIEW_TEXT] => We are pleased to inform you that starting from September 17, BIOCARD offers FTL transportation using its fleet. It's even more convenient now! Competitive rates. Experienced drivers. All directions. Cargo safety. [PREVIEW_TEXT_TYPE] => html [~PREVIEW_TEXT_TYPE] => html [PREVIEW_PICTURE] => Array ( [ID] => 984 [TIMESTAMP_X] => Bitrix\Main\Type\DateTime Object ( [userTimeEnabled:protected] => 1 [value:protected] => DateTime Object ( [date] => 2021-08-11 16:33:45.000000 [timezone_type] => 3 [timezone] => Europe/Moscow ) ) [MODULE_ID] => iblock [HEIGHT] => 300 [WIDTH] => 367 [FILE_SIZE] => 22649 [CONTENT_TYPE] => image/jpeg [SUBDIR] => iblock/014 [FILE_NAME] => 014ed2ed669cf1def8845f248d473088.jpg [ORIGINAL_NAME] => 014ed2ed669cf1def8845f248d473088.jpg [DESCRIPTION] => [HANDLER_ID] => [EXTERNAL_ID] => 65fa3e1c0c68b1fd0747de870fa52b78 [~src] => [SRC] => /upload/iblock/014/014ed2ed669cf1def8845f248d473088.jpg [UNSAFE_SRC] => /upload/iblock/014/014ed2ed669cf1def8845f248d473088.jpg [SAFE_SRC] => /upload/iblock/014/014ed2ed669cf1def8845f248d473088.jpg [ALT] => BIOCARD OFFERS A NEW SERVICE: FTL-TRANSPORTATION [TITLE] => BIOCARD OFFERS A NEW SERVICE: FTL-TRANSPORTATION ) [~PREVIEW_PICTURE] => 984 [LANG_DIR] => /en/ [~LANG_DIR] => /en/ [CODE] => biocard-otkryvaet-novoe-napravlenie-ftl-perevozka [~CODE] => biocard-otkryvaet-novoe-napravlenie-ftl-perevozka [EXTERNAL_ID] => 340 [~EXTERNAL_ID] => 340 [IBLOCK_TYPE_ID] => news [~IBLOCK_TYPE_ID] => news [IBLOCK_CODE] => [~IBLOCK_CODE] => [IBLOCK_EXTERNAL_ID] => [~IBLOCK_EXTERNAL_ID] => [LID] => s2 [~LID] => s2 [EDIT_LINK] => [DELETE_LINK] => [DISPLAY_ACTIVE_FROM] => 17.09.2020 [FIELDS] => Array ( ) [DISPLAY_PROPERTIES] => Array ( ) [IPROPERTY_VALUES] => Array ( ) )

Array ( [ID] => 331 [~ID] => 331 [IBLOCK_ID] => 39 [~IBLOCK_ID] => 39 [IBLOCK_SECTION_ID] => [~IBLOCK_SECTION_ID] => [NAME] => THE FIRST BATCH OF CORONAVIRUS VACCINE HAS BEEN SENT TO THE REGIONS OF RUSSIA [~NAME] => THE FIRST BATCH OF CORONAVIRUS VACCINE HAS BEEN SENT TO THE REGIONS OF RUSSIA [ACTIVE_FROM] => 09/15/2020 [~ACTIVE_FROM] => 09/15/2020 [TIMESTAMP_X] => 08/11/2021 04:34:03 pm [~TIMESTAMP_X] => 08/11/2021 04:34:03 pm [DETAIL_PAGE_URL] => /en/news/pervaya-partiya-vaktsiny-ot-koronavirusa-napravlena-v-regiony-rossii/ [~DETAIL_PAGE_URL] => /en/news/pervaya-partiya-vaktsiny-ot-koronavirusa-napravlena-v-regiony-rossii/ [LIST_PAGE_URL] => /en/news/ [~LIST_PAGE_URL] => /en/news/ [DETAIL_TEXT] => [~DETAIL_TEXT] => [DETAIL_TEXT_TYPE] => text [~DETAIL_TEXT_TYPE] => text [PREVIEW_TEXT] => "Biocard Logistics" has sent to the regions the first batch of the «Sputnik V» vaccine (Gam-COVID-Vac), developed by the National Research Center of Epidemiology and Microbiology named after Honorary Academician N. F. Gamaleya of the Ministry of Health of the Russian Federation. The first shipments will be received in 10-15 regions of the country.



SAFEPACK insulated containers developed and manufactured by Biocard Logistics were used for the world's first delivery of a coronavirus vaccine. The insulated containers are made of high-quality materials and maintain a pre-set temperature regime for up to 10 days.

The Temperature Control System developed by "Biocard Logistics" provides remote monitoring of temperature in real-time at all stages of vaccine transportation.

[~PREVIEW_TEXT] => "Biocard Logistics" has sent to the regions the first batch of the «Sputnik V» vaccine (Gam-COVID-Vac), developed by the National Research Center of Epidemiology and Microbiology named after Honorary Academician N. F. Gamaleya of the Ministry of Health of the Russian Federation. The first shipments will be received in 10-15 regions of the country.



SAFEPACK insulated containers developed and manufactured by Biocard Logistics were used for the world's first delivery of a coronavirus vaccine. The insulated containers are made of high-quality materials and maintain a pre-set temperature regime for up to 10 days.

The Temperature Control System developed by "Biocard Logistics" provides remote monitoring of temperature in real-time at all stages of vaccine transportation.

[PREVIEW_TEXT_TYPE] => html [~PREVIEW_TEXT_TYPE] => html [PREVIEW_PICTURE] => Array ( [ID] => 975 [TIMESTAMP_X] => Bitrix\Main\Type\DateTime Object ( [userTimeEnabled:protected] => 1 [value:protected] => DateTime Object ( [date] => 2021-08-11 16:34:03.000000 [timezone_type] => 3 [timezone] => Europe/Moscow ) ) [MODULE_ID] => iblock [HEIGHT] => 300 [WIDTH] => 367 [FILE_SIZE] => 20894 [CONTENT_TYPE] => image/jpeg [SUBDIR] => iblock/151 [FILE_NAME] => 15100e12a8885c092737ef70c64e23e9.jpg [ORIGINAL_NAME] => 15100e12a8885c092737ef70c64e23e9.jpg [DESCRIPTION] => [HANDLER_ID] => [EXTERNAL_ID] => 023fc0e5f101cf5c8095c8685f177abd [~src] => [SRC] => /upload/iblock/151/15100e12a8885c092737ef70c64e23e9.jpg [UNSAFE_SRC] => /upload/iblock/151/15100e12a8885c092737ef70c64e23e9.jpg [SAFE_SRC] => /upload/iblock/151/15100e12a8885c092737ef70c64e23e9.jpg [ALT] => THE FIRST BATCH OF CORONAVIRUS VACCINE HAS BEEN SENT TO THE REGIONS OF RUSSIA [TITLE] => THE FIRST BATCH OF CORONAVIRUS VACCINE HAS BEEN SENT TO THE REGIONS OF RUSSIA ) [~PREVIEW_PICTURE] => 975 [LANG_DIR] => /en/ [~LANG_DIR] => /en/ [CODE] => pervaya-partiya-vaktsiny-ot-koronavirusa-napravlena-v-regiony-rossii [~CODE] => pervaya-partiya-vaktsiny-ot-koronavirusa-napravlena-v-regiony-rossii [EXTERNAL_ID] => 331 [~EXTERNAL_ID] => 331 [IBLOCK_TYPE_ID] => news [~IBLOCK_TYPE_ID] => news [IBLOCK_CODE] => [~IBLOCK_CODE] => [IBLOCK_EXTERNAL_ID] => [~IBLOCK_EXTERNAL_ID] => [LID] => s2 [~LID] => s2 [EDIT_LINK] => [DELETE_LINK] => [DISPLAY_ACTIVE_FROM] => 15.09.2020 [FIELDS] => Array ( ) [DISPLAY_PROPERTIES] => Array ( ) [IPROPERTY_VALUES] => Array ( ) )

Array ( [ID] => 330 [~ID] => 330 [IBLOCK_ID] => 39 [~IBLOCK_ID] => 39 [IBLOCK_SECTION_ID] => [~IBLOCK_SECTION_ID] => [NAME] => BIOCARD DELIVERED THE FIRST BATCH OF CORONAVIRUS VACCINE [~NAME] => BIOCARD DELIVERED THE FIRST BATCH OF CORONAVIRUS VACCINE [ACTIVE_FROM] => 09/04/2020 [~ACTIVE_FROM] => 09/04/2020 [TIMESTAMP_X] => 08/11/2021 04:34:16 pm [~TIMESTAMP_X] => 08/11/2021 04:34:16 pm [DETAIL_PAGE_URL] => /en/news/biocard-postavil-pervuyu-partiyu-vaktsiny-ot-koronovirusa/ [~DETAIL_PAGE_URL] => /en/news/biocard-postavil-pervuyu-partiyu-vaktsiny-ot-koronovirusa/ [LIST_PAGE_URL] => /en/news/ [~LIST_PAGE_URL] => /en/news/ [DETAIL_TEXT] => [~DETAIL_TEXT] => [DETAIL_TEXT_TYPE] => text [~DETAIL_TEXT_TYPE] => text [PREVIEW_TEXT] => "Biocard Logistics" announced the delivery of the first doses of the COVID-19 vaccine to the capital's out-patient clinics No. 2, 62, and 220 for post-registration clinical studies.

"According to preliminary data, the vaccine supply market will increase to more than a billion dollars," said Oleg Baykov, Deputy General Director of Biocard Logistics. – Not only state-owned companies are interested in it, but also private companies, and what the market segments will be is highly questionable.”

Special conditions are required for transporting the vaccine, and the cost of a mistake is too high. Therefore, the selection of a logistics operator for the world's first delivery of a vaccine against a deadly virus was approached with the highest responsibility, he stressed, adding that "not every logistics company has necessary resources to implement such delivery."

"The most complex vaccine supply in the world was entrusted to Biocard Logistics, proving that our full-service logistics company is a reliable partner for leading pharmaceutical and healthcare providers not only in Russia but also globally," Oleg Baykov said.

According to the expert, the vaccine requires a new generation of logistics services, which should include an IT ecosystem for all participants in the supply chain, "smart insulated containers" capable of maintaining the necessary temperature for up to 240 hours, a temperature control system and a mobile application for customers.

According to him, the temperature control system of "Biocard Logistics" fully meets these requirements. It "allows remote monitoring of temperature in real-time during the transportation of temperature-sensitive medicines and vaccines." [~PREVIEW_TEXT] => "Biocard Logistics" announced the delivery of the first doses of the COVID-19 vaccine to the capital's out-patient clinics No. 2, 62, and 220 for post-registration clinical studies.

"According to preliminary data, the vaccine supply market will increase to more than a billion dollars," said Oleg Baykov, Deputy General Director of Biocard Logistics. – Not only state-owned companies are interested in it, but also private companies, and what the market segments will be is highly questionable.”

Special conditions are required for transporting the vaccine, and the cost of a mistake is too high. Therefore, the selection of a logistics operator for the world's first delivery of a vaccine against a deadly virus was approached with the highest responsibility, he stressed, adding that "not every logistics company has necessary resources to implement such delivery."

"The most complex vaccine supply in the world was entrusted to Biocard Logistics, proving that our full-service logistics company is a reliable partner for leading pharmaceutical and healthcare providers not only in Russia but also globally," Oleg Baykov said.

According to the expert, the vaccine requires a new generation of logistics services, which should include an IT ecosystem for all participants in the supply chain, "smart insulated containers" capable of maintaining the necessary temperature for up to 240 hours, a temperature control system and a mobile application for customers.

According to him, the temperature control system of "Biocard Logistics" fully meets these requirements. It "allows remote monitoring of temperature in real-time during the transportation of temperature-sensitive medicines and vaccines." [PREVIEW_TEXT_TYPE] => html [~PREVIEW_TEXT_TYPE] => html [PREVIEW_PICTURE] => Array ( [ID] => 974 [TIMESTAMP_X] => Bitrix\Main\Type\DateTime Object ( [userTimeEnabled:protected] => 1 [value:protected] => DateTime Object ( [date] => 2021-08-11 16:34:16.000000 [timezone_type] => 3 [timezone] => Europe/Moscow ) ) [MODULE_ID] => iblock [HEIGHT] => 300 [WIDTH] => 367 [FILE_SIZE] => 27333 [CONTENT_TYPE] => image/jpeg [SUBDIR] => iblock/967 [FILE_NAME] => 96741d05afca55c670f27da5c326757c.jpg [ORIGINAL_NAME] => 96741d05afca55c670f27da5c326757c.jpg [DESCRIPTION] => [HANDLER_ID] => [EXTERNAL_ID] => 6d15e786a3fc652348927a101fa799b8 [~src] => [SRC] => /upload/iblock/967/96741d05afca55c670f27da5c326757c.jpg [UNSAFE_SRC] => /upload/iblock/967/96741d05afca55c670f27da5c326757c.jpg [SAFE_SRC] => /upload/iblock/967/96741d05afca55c670f27da5c326757c.jpg [ALT] => BIOCARD DELIVERED THE FIRST BATCH OF CORONAVIRUS VACCINE [TITLE] => BIOCARD DELIVERED THE FIRST BATCH OF CORONAVIRUS VACCINE ) [~PREVIEW_PICTURE] => 974 [LANG_DIR] => /en/ [~LANG_DIR] => /en/ [CODE] => biocard-postavil-pervuyu-partiyu-vaktsiny-ot-koronovirusa [~CODE] => biocard-postavil-pervuyu-partiyu-vaktsiny-ot-koronovirusa [EXTERNAL_ID] => 330 [~EXTERNAL_ID] => 330 [IBLOCK_TYPE_ID] => news [~IBLOCK_TYPE_ID] => news [IBLOCK_CODE] => [~IBLOCK_CODE] => [IBLOCK_EXTERNAL_ID] => [~IBLOCK_EXTERNAL_ID] => [LID] => s2 [~LID] => s2 [EDIT_LINK] => [DELETE_LINK] => [DISPLAY_ACTIVE_FROM] => 04.09.2020 [FIELDS] => Array ( ) [DISPLAY_PROPERTIES] => Array ( ) [IPROPERTY_VALUES] => Array ( ) )

Array ( [ID] => 328 [~ID] => 328 [IBLOCK_ID] => 39 [~IBLOCK_ID] => 39 [IBLOCK_SECTION_ID] => [~IBLOCK_SECTION_ID] => [NAME] => HOW BIOCARD'S PROPRIETARY SOLUTIONS HELP PHARMACEUTICAL COMPANIES MAINTAIN PRODUCT QUALITY [~NAME] => HOW BIOCARD'S PROPRIETARY SOLUTIONS HELP PHARMACEUTICAL COMPANIES MAINTAIN PRODUCT QUALITY [ACTIVE_FROM] => 09/04/2020 [~ACTIVE_FROM] => 09/04/2020 [TIMESTAMP_X] => 08/11/2021 04:34:29 pm [~TIMESTAMP_X] => 08/11/2021 04:34:29 pm [DETAIL_PAGE_URL] => /en/news/kak-sobstvennye-razrabotki-biocard-pomogayut-farmkompaniyam-sokhranyat-kachestvo-produktsii/ [~DETAIL_PAGE_URL] => /en/news/kak-sobstvennye-razrabotki-biocard-pomogayut-farmkompaniyam-sokhranyat-kachestvo-produktsii/ [LIST_PAGE_URL] => /en/news/ [~LIST_PAGE_URL] => /en/news/ [DETAIL_TEXT] => [~DETAIL_TEXT] => [DETAIL_TEXT_TYPE] => text [~DETAIL_TEXT_TYPE] => text [PREVIEW_TEXT] => Traditionally, the key factor in the selection of a logistics provider is the price, and the second priority is the time of delivery. However, when it comes to choosing a carrier of pharmaceutical products, it is crucial to have guarantees of the safety of the cargo properties during transportation.

Oleg Baykov, Deputy General Director of Biocard Logistics, talks about how Biocard Logistics develops services and improves technologies for providing qualitative delivery and storage of thermolabile cargoes.

A PROBLEM THAT REQUIRES AN IMMEDIATE DECISION
In 2019, the volume of the global pharmaceutical logistics market amounted to $ 69 billion and is projected to grow with an average annual growth rate (CAGR) of 7.3% from 2020 to 2027. The short-term impact of COVID-19 on the market has become a critical factor for the rapid growth of pharmaceutical logistics worldwide. In the context of a pandemic, Governments around the world are paying special attention to healthcare organizations and providing patients with a sufficient amount of medicines. Thus, the sales of conventional medicines are increasing in every country. The value of the global pharmaceutical market is $76.4 billion. Due to temperature failures during transportation, individuals in charge of making decisions in logistics regularly report damage to a third of all delivered products. If we consider pharmaceuticals that require "cold chain» logistics, where the highest risk is associated with exceeding temperature limits, this means that products worth from $110 billion to $300 million per day are at risk! This is a huge number of medicines that potentially do not reach their recipients on time or do not reach them at all. Solving this challenge will bring significant benefits to the pharmaceutical business.

Due to the deterioration of the epidemiological situation in the world, a large number of very valuable and temperature-sensitive biopharmaceuticals will enter the market shortly. This also means that the cost of shipping temperature-sensitive goods will increase along with the increase in the cost of medicines. And, of course, the total losses caused by temperature failures during transportation amount to more than the cost of a pallet or a container with a drug.

In addition, in the logistics of pharmaceuticals, we are dealing with products that are of critical importance for patients: life and death. Therefore, any transportation ultimately creates waiting time, additional costs, and even possible physical harm and discomfort for a patient who must take this medicine. Therefore, safety and high quality are of paramount importance in pharmaceutical logistics. And since the assessment of processes is impossible without key performance indicators, an effective way to control compliance with the "cold chain» is necessary. One of the ways to achieve this is to introduce a comprehensive Temperature Monitoring System into the process.

DEVELOPMENT OF PROPRIETARY TECHNOLOGIES
In 1989, Biocard Logistics specialized only in the logistics for clinical studies. Gradually, the volume of the shipments increased, the logistics provider developed at an accelerated pace, expanding the range of services for customers, accumulating "best practices" and professionalism in the delivery and storage of medical products. Today, biocard logistics is a full-service logistics company with 30 years of experience, a reliable partner for leading pharmaceutical and healthcare organizations not only in russia but also globally. Since the pharmaceutical market is the largest, requiring specialized logistics services and storage of temperature-sensitive cargoes, competition is very high. Every year, the requirements for logistics providers are increasing.


Compliance with the requirements of the "cold chain» during the storage and transportation of medicines is one of the priorities in ensuring the safety of vaccination of the population. According to statistics, about a third of the pharmaceutical products of the "cold chain» are at risk every year and do not reach their destination due to temperature failures. To solve this challenge, market participants are developing various technologies. The lack of a suitable vaccine against covid-19 increases the burden on the health of the population in the world. Researchers and clinicians around the world are experimenting with drugs to find a cure for covid-19.

Biocard Logistics goes with the times, responding to new challenges, and in line with the growing demand of the market in studies, manufacturing, and launching preventive and therapeutic medicines. The introduction of process automation allows biocard to improve the efficiency and safety of cargo carriage. In addition, the implementation and development of temperature control solutions in refrigerators and containers make it possible to remotely monitor the temperature in real-time during the transportation of temperature-sensitive medicines and vaccines. The use of the iot system allows to predict the possible risks of temperature failures along the routes and eliminates temperature instability.

The global digitalization trend is also a driver for the development and implementation of proprietary technologies. The development of own erp system, online services for couriers and customers are just the first steps in the automation of business processes. Priority is given to solutions aimed at accelerating cargo delivery, processes control, and integration into a single digital platform.


Biocard logistics continuously invests in new technologies, improving customer service, increasing the convenience and quality of delivery and other services. When transporting thermolabile goods, the ability to monitor and track the movement of goods in real-time is of critical importance. We apply a technological approached to implement these opportunities, so in september 2019 we started developing our e-platforms for couriers and customers. The mobile application for biocard mobile customers is a specially designed software that helps our customers control the delivery process and simplifies operations. Direct control of all stages and processes gives confidence in the timely delivery of cargoes and the preservation of the properties and quality of pharmaceutical cargoes. Auto-push notifications in the mobile app, showing every change in the cargo status, increase the transparency and traceability of the supply chain and directly contribute to customer satisfaction with the range of services. In the mobile application, you can make a delivery request, download copies of documents, scroll through the order history and documents for all orders. Within 3 months after the launch of the mobile application, it showed excellent performance. Today, more than 800 customers use the biocard mobile app.

For couriers, we have developed a personal account on the website that facilitates distributing orders and plans effective delivery routes, as well as makes the delivery for couriers much easier.

One of the key indicators of the quality of our work is in-time execution and no temperature failures. Every year we exceed planned indicators values, striving for perfection of services for our clients.



A SAFEPACK ECOSYSTEM. SMART INSULATED CONTAINERS AND SMART SENSORS
We have launched the project of the unified Safepack ecosystem and the development of smart insulated containers that preserve the temperature regimes for up to 240 hours. After conducting a series of tests of insulated containers, the thermal sensors showed 100% temperature stability. Now we have expanded the range of insulated containers to 17 models, offering variety in volume, weight, and manufacturing materials.


The development of insulated containers prompted the development of our own temperature-sensitive element, which will be integrated into the insulated containers. Using this technology our clients will be able to track the entire delivery process in real-time and check location and cargo temperature in transit. Our clients have full access to all possible parameters: location control, temperature, container opening, batteries status, vibration, movement, impact, cargo fall. The smart sensor measures not only the inside temperature in the container but also the ambient temperature. This makes it possible for our clients to be completely confident in the safety of their cargoes. Taking into account the continuous growth of the “cold chain» cargoes delivery volumes, we relied on all processes automation and human factor mitigation. The automatic temperature control solution ensures quality and safety, as well as increases the efficiency of handling by reducing manual work. This technology allows reducing the number of temperature failures, avoiding the delivery of substitute products, also contributes to conducting a more environmentally sustainable business. With the integration of the Smart Sensor and the Biocard Mobile application, we completely automated orders delivery excluding physical monitoring.



SPECIAL ASPECTS OF DELIVERY OF MEDICAL AND PHARMACEUTICAL GOODS
Today, 80% of the shipments handled by Biocard Logistics are medical and pharmaceutical goods – vaccines, medicines, biomaterials, etc. When organizing delivery for our clients, we take into account many factors that are important for a client: time, weight and dimensions of goods, the required temperature regime, the capacity of insulated containers, the compatibility of goods, and so on. All these requirements are individual and need a custom-tailored approach. Taking into account a huge amount of information necessary for the customer and by testing hypotheses, we create high-quality service. The key goal of the proprietary developments is to expand global presence, provide high-quality services, streamline the process of interaction with our customers. To automate the processing, we have developed an ITIL system based on 1C – a system for managing incoming orders. It allowed us to improve the work of employees responsible for processing orders and to regulate smoothly the flow of incoming orders in real-time.

INNOVATIONS IN OUR SERVICES
By the well-coordinated work of our team, we were able to quickly launch innovations and obtain the improvements. Now we have significantly increased operations in all areas and perform services using our proprietary technological developments. The speed of orders handling has increased by 30%. We strive to create a seamless experience for our customers, and we continue to work on improving and scaling the service quality. Biocard completely changes the approach to logistics. [~PREVIEW_TEXT] => Traditionally, the key factor in the selection of a logistics provider is the price, and the second priority is the time of delivery. However, when it comes to choosing a carrier of pharmaceutical products, it is crucial to have guarantees of the safety of the cargo properties during transportation.

Oleg Baykov, Deputy General Director of Biocard Logistics, talks about how Biocard Logistics develops services and improves technologies for providing qualitative delivery and storage of thermolabile cargoes.

A PROBLEM THAT REQUIRES AN IMMEDIATE DECISION
In 2019, the volume of the global pharmaceutical logistics market amounted to $ 69 billion and is projected to grow with an average annual growth rate (CAGR) of 7.3% from 2020 to 2027. The short-term impact of COVID-19 on the market has become a critical factor for the rapid growth of pharmaceutical logistics worldwide. In the context of a pandemic, Governments around the world are paying special attention to healthcare organizations and providing patients with a sufficient amount of medicines. Thus, the sales of conventional medicines are increasing in every country. The value of the global pharmaceutical market is $76.4 billion. Due to temperature failures during transportation, individuals in charge of making decisions in logistics regularly report damage to a third of all delivered products. If we consider pharmaceuticals that require "cold chain» logistics, where the highest risk is associated with exceeding temperature limits, this means that products worth from $110 billion to $300 million per day are at risk! This is a huge number of medicines that potentially do not reach their recipients on time or do not reach them at all. Solving this challenge will bring significant benefits to the pharmaceutical business.

Due to the deterioration of the epidemiological situation in the world, a large number of very valuable and temperature-sensitive biopharmaceuticals will enter the market shortly. This also means that the cost of shipping temperature-sensitive goods will increase along with the increase in the cost of medicines. And, of course, the total losses caused by temperature failures during transportation amount to more than the cost of a pallet or a container with a drug.

In addition, in the logistics of pharmaceuticals, we are dealing with products that are of critical importance for patients: life and death. Therefore, any transportation ultimately creates waiting time, additional costs, and even possible physical harm and discomfort for a patient who must take this medicine. Therefore, safety and high quality are of paramount importance in pharmaceutical logistics. And since the assessment of processes is impossible without key performance indicators, an effective way to control compliance with the "cold chain» is necessary. One of the ways to achieve this is to introduce a comprehensive Temperature Monitoring System into the process.

DEVELOPMENT OF PROPRIETARY TECHNOLOGIES
In 1989, Biocard Logistics specialized only in the logistics for clinical studies. Gradually, the volume of the shipments increased, the logistics provider developed at an accelerated pace, expanding the range of services for customers, accumulating "best practices" and professionalism in the delivery and storage of medical products. Today, biocard logistics is a full-service logistics company with 30 years of experience, a reliable partner for leading pharmaceutical and healthcare organizations not only in russia but also globally. Since the pharmaceutical market is the largest, requiring specialized logistics services and storage of temperature-sensitive cargoes, competition is very high. Every year, the requirements for logistics providers are increasing.


Compliance with the requirements of the "cold chain» during the storage and transportation of medicines is one of the priorities in ensuring the safety of vaccination of the population. According to statistics, about a third of the pharmaceutical products of the "cold chain» are at risk every year and do not reach their destination due to temperature failures. To solve this challenge, market participants are developing various technologies. The lack of a suitable vaccine against covid-19 increases the burden on the health of the population in the world. Researchers and clinicians around the world are experimenting with drugs to find a cure for covid-19.

Biocard Logistics goes with the times, responding to new challenges, and in line with the growing demand of the market in studies, manufacturing, and launching preventive and therapeutic medicines. The introduction of process automation allows biocard to improve the efficiency and safety of cargo carriage. In addition, the implementation and development of temperature control solutions in refrigerators and containers make it possible to remotely monitor the temperature in real-time during the transportation of temperature-sensitive medicines and vaccines. The use of the iot system allows to predict the possible risks of temperature failures along the routes and eliminates temperature instability.

The global digitalization trend is also a driver for the development and implementation of proprietary technologies. The development of own erp system, online services for couriers and customers are just the first steps in the automation of business processes. Priority is given to solutions aimed at accelerating cargo delivery, processes control, and integration into a single digital platform.


Biocard logistics continuously invests in new technologies, improving customer service, increasing the convenience and quality of delivery and other services. When transporting thermolabile goods, the ability to monitor and track the movement of goods in real-time is of critical importance. We apply a technological approached to implement these opportunities, so in september 2019 we started developing our e-platforms for couriers and customers. The mobile application for biocard mobile customers is a specially designed software that helps our customers control the delivery process and simplifies operations. Direct control of all stages and processes gives confidence in the timely delivery of cargoes and the preservation of the properties and quality of pharmaceutical cargoes. Auto-push notifications in the mobile app, showing every change in the cargo status, increase the transparency and traceability of the supply chain and directly contribute to customer satisfaction with the range of services. In the mobile application, you can make a delivery request, download copies of documents, scroll through the order history and documents for all orders. Within 3 months after the launch of the mobile application, it showed excellent performance. Today, more than 800 customers use the biocard mobile app.

For couriers, we have developed a personal account on the website that facilitates distributing orders and plans effective delivery routes, as well as makes the delivery for couriers much easier.

One of the key indicators of the quality of our work is in-time execution and no temperature failures. Every year we exceed planned indicators values, striving for perfection of services for our clients.



A SAFEPACK ECOSYSTEM. SMART INSULATED CONTAINERS AND SMART SENSORS
We have launched the project of the unified Safepack ecosystem and the development of smart insulated containers that preserve the temperature regimes for up to 240 hours. After conducting a series of tests of insulated containers, the thermal sensors showed 100% temperature stability. Now we have expanded the range of insulated containers to 17 models, offering variety in volume, weight, and manufacturing materials.


The development of insulated containers prompted the development of our own temperature-sensitive element, which will be integrated into the insulated containers. Using this technology our clients will be able to track the entire delivery process in real-time and check location and cargo temperature in transit. Our clients have full access to all possible parameters: location control, temperature, container opening, batteries status, vibration, movement, impact, cargo fall. The smart sensor measures not only the inside temperature in the container but also the ambient temperature. This makes it possible for our clients to be completely confident in the safety of their cargoes. Taking into account the continuous growth of the “cold chain» cargoes delivery volumes, we relied on all processes automation and human factor mitigation. The automatic temperature control solution ensures quality and safety, as well as increases the efficiency of handling by reducing manual work. This technology allows reducing the number of temperature failures, avoiding the delivery of substitute products, also contributes to conducting a more environmentally sustainable business. With the integration of the Smart Sensor and the Biocard Mobile application, we completely automated orders delivery excluding physical monitoring.



SPECIAL ASPECTS OF DELIVERY OF MEDICAL AND PHARMACEUTICAL GOODS
Today, 80% of the shipments handled by Biocard Logistics are medical and pharmaceutical goods – vaccines, medicines, biomaterials, etc. When organizing delivery for our clients, we take into account many factors that are important for a client: time, weight and dimensions of goods, the required temperature regime, the capacity of insulated containers, the compatibility of goods, and so on. All these requirements are individual and need a custom-tailored approach. Taking into account a huge amount of information necessary for the customer and by testing hypotheses, we create high-quality service. The key goal of the proprietary developments is to expand global presence, provide high-quality services, streamline the process of interaction with our customers. To automate the processing, we have developed an ITIL system based on 1C – a system for managing incoming orders. It allowed us to improve the work of employees responsible for processing orders and to regulate smoothly the flow of incoming orders in real-time.

INNOVATIONS IN OUR SERVICES
By the well-coordinated work of our team, we were able to quickly launch innovations and obtain the improvements. Now we have significantly increased operations in all areas and perform services using our proprietary technological developments. The speed of orders handling has increased by 30%. We strive to create a seamless experience for our customers, and we continue to work on improving and scaling the service quality. Biocard completely changes the approach to logistics. [PREVIEW_TEXT_TYPE] => html [~PREVIEW_TEXT_TYPE] => html [PREVIEW_PICTURE] => Array ( [ID] => 971 [TIMESTAMP_X] => Bitrix\Main\Type\DateTime Object ( [userTimeEnabled:protected] => 1 [value:protected] => DateTime Object ( [date] => 2021-08-11 16:34:29.000000 [timezone_type] => 3 [timezone] => Europe/Moscow ) ) [MODULE_ID] => iblock [HEIGHT] => 300 [WIDTH] => 367 [FILE_SIZE] => 29515 [CONTENT_TYPE] => image/jpeg [SUBDIR] => iblock/bf6 [FILE_NAME] => bf6999899d41f1b716d937fd9abc1cc4.jpg [ORIGINAL_NAME] => bf6999899d41f1b716d937fd9abc1cc4.jpg [DESCRIPTION] => [HANDLER_ID] => [EXTERNAL_ID] => b895e2d922c065a9652d9e3ab9b5cd64 [~src] => [SRC] => /upload/iblock/bf6/bf6999899d41f1b716d937fd9abc1cc4.jpg [UNSAFE_SRC] => /upload/iblock/bf6/bf6999899d41f1b716d937fd9abc1cc4.jpg [SAFE_SRC] => /upload/iblock/bf6/bf6999899d41f1b716d937fd9abc1cc4.jpg [ALT] => HOW BIOCARD'S PROPRIETARY SOLUTIONS HELP PHARMACEUTICAL COMPANIES MAINTAIN PRODUCT QUALITY [TITLE] => HOW BIOCARD'S PROPRIETARY SOLUTIONS HELP PHARMACEUTICAL COMPANIES MAINTAIN PRODUCT QUALITY ) [~PREVIEW_PICTURE] => 971 [LANG_DIR] => /en/ [~LANG_DIR] => /en/ [CODE] => kak-sobstvennye-razrabotki-biocard-pomogayut-farmkompaniyam-sokhranyat-kachestvo-produktsii [~CODE] => kak-sobstvennye-razrabotki-biocard-pomogayut-farmkompaniyam-sokhranyat-kachestvo-produktsii [EXTERNAL_ID] => 328 [~EXTERNAL_ID] => 328 [IBLOCK_TYPE_ID] => news [~IBLOCK_TYPE_ID] => news [IBLOCK_CODE] => [~IBLOCK_CODE] => [IBLOCK_EXTERNAL_ID] => [~IBLOCK_EXTERNAL_ID] => [LID] => s2 [~LID] => s2 [EDIT_LINK] => [DELETE_LINK] => [DISPLAY_ACTIVE_FROM] => 04.09.2020 [FIELDS] => Array ( ) [DISPLAY_PROPERTIES] => Array ( ) [IPROPERTY_VALUES] => Array ( ) )